B3GNT5 and central nervous system cancer: Since our study demonstrated the elevated expression of B3GNT5 in GSCs, a comparative structural analysis of B3GNT5‐based glycolipids such as SGGL and Lewis X on GSCs will be performed in our next study to elucidate the structure of the major glycolipid controlling the stemness of glioma stem cells.